UTMD News and Press, Utah Medical Products Inc. From 10/02/22

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...

Summary Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate. The Summers Value Fund LP (“the Fund”) returned -25.9% net in the first ...

Utah Medical Products press release ( NASDAQ: UTMD ): Q2 GAAP EPS of $1.12. Revenue of $13.4M (+6.3% Y/Y). For further details see: Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

SALT LAKE CITY, UT - ( NewMediaWire ) - July 26, 2022 - UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia ...

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a monthly...

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...

Utah Medical Products (NASDAQ:UTMD) declares $0.29/share quarterly dividend, in line with previous. Forward yield 1.39% Payable July 6; for shareholders of record June 17; ex-div June 16. See UTMD Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Utah Medi...

Utah Medical Products press release (NASDAQ:UTMD): Q1 GAAP EPS of $0.964. Revenue of $12.32M (+12.4% Y/Y). For further details see: Utah Medical Products GAAP EPS of $0.964, revenue of $12.32M

SALT LAKE CITY, UT, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent with achieving its goals for calendar year 2022. Summary of results . ...